140: Bortezomib Plus Tacrolimus/Methotrexate for Prophylaxis of Acute GVHD after HLA Mismatched Allogeneic Non-Myeloablative Transplantation: Results of a Dose Finding Phase I Study
140: Bortezomib Plus Tacrolimus/Methotrexate for Prophylaxis of Acute GVHD after HLA Mismatched Allogeneic Non-Myeloablative Transplantation: Results of a Dose Finding Phase I Study
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started